Designed bacterial compositions and uses thereof
US-2025367242-A1 · Dec 4, 2025 · US
This page is not indexed by search engines while we improve data quality.
Seres Therapeutics Inc — Cross-Sectional Technologies
Seres Therapeutics Inc holds 58 patents in Cross-Sectional Technologies, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Seres Therapeutics Inc |
| Technology | Cross-Sectional Technologies |
| Patents in slice | 58 |
| Recent patents in slice | 15 |
| First year | 2015 |
| Last year | 2025 |
Representative patents
Notable publications linking Seres Therapeutics Inc to Cross-Sectional Technologies.
Compositions and methods for treating antibiotic resistance
US-2025288625-A1 · Sep 18, 2025 · US
Synergistic bacterial compositions and methods of production and use thereof
US-12409197-B2 · Sep 9, 2025 · US
Synergistic bacterial compositions and methods of production and use thereof
US-2025064869-A1 · Feb 27, 2025 · US
Compositions and methods for treating antibiotic resistance
US-12214002-B2 · Feb 4, 2025 · US
Recent filings
Latest patents from Seres Therapeutics Inc in Cross-Sectional Technologies.
Designed bacterial compositions and uses thereof
US-2025367242-A1 · Dec 4, 2025 · US
Compositions and methods for treating antibiotic resistance
US-2025288625-A1 · Sep 18, 2025 · US
Synergistic bacterial compositions and methods of production and use thereof
US-12409197-B2 · Sep 9, 2025 · US
Synergistic bacterial compositions and methods of production and use thereof
US-2025064869-A1 · Feb 27, 2025 · US
Compositions and methods for treating antibiotic resistance
US-12214002-B2 · Feb 4, 2025 · US
Related pages
Navigate to parent entity pages.